Stroke. 'Spotting' patients at the highest risk of hematoma growth.
Clinical trials aimed at preventing hematoma expansion in patients with intraparenchymal hemorrhage have failed to show benefit from experimental intervention. novel methods for identifying those patients at the highest risk of hemorrhage growth might enable better patient selection and, hence, increase the chance of demonstrating an improvement in clinical outcome.
University of Washington School of Medicine, Harborview Medical Center, 325 9th Avenue,Seattle, WA 98104, USA. kjb@u.washington.edu
Kyra
K
Becker
David
D
Tirschwell
D002533:Cerebral Angiography; D002986:Clinical Trials as Topic; D006406:Hematoma / Q000000981:diagnostic imaging* / Q000209:etiology*; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000150:complications*